相关实验视频
Updated: Jun 12, 2025

07:28
Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
9.1K
心肌梗塞相关的休克:表型的全面分析,SCAI分类和结果评估
Stanislav Dil1, Maria Kercheva1,2, Oleg Panteleev1,2
1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 119334, Russia.
Medicina (Kaunas, Lithuania)
|January 25, 2025
概括
混合性休克 (MS) 在心肌梗塞中复杂的心脏性休克 (MI-CS) 导致死亡率更高. 机械通风,高乳糖和心肺复苏预测死亡,而动脉内气球的使用和更高的BMI提高了MI-CS患者的生存率.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 临床研究 临床研究
背景情况:
- 由心脏性休克 (MI-CS) 复杂的心肌梗塞在医院死亡率很高.
- 混合性休克 (MS) 结合了心脏性休克与分配因素,恶化了结果.
- 在MI-CS患者中,MS会带来诊断和治疗方面的挑战.
研究的目的:
- 分析MI-CS表型的临床,历史,仪器和实验室特征.
- 使用心血管血管血管学和干预学会 (SCAI) 的冲击严重程度尺度来分层MI-CS表型.
- 确定MI-CS患者死亡率和生存率的预测因素.
主要方法:
- 对117名MI-CS患者进行了回顾性观察研究.
- 患者分为MS (n=48) 和孤立的CS (n=69) 组.
- 后勤回归分析用于识别死亡率预测因素.
主要成果:
- 多发性硬化症患者年龄较大 (80岁与73岁相比),死亡率明显较高 (68%与53%相比).
- 死亡率的独立预测因素:机械呼吸,乳酸水平升高,心肺复苏 (CPR).
- 生存的保护因素:使用大动脉内气球 (IABP) 和更高的体重指数 (BMI).
结论:
- 多发性硬化是MI-CS的一个独特的临床表型,结果更差.
- 早期识别死亡预测因素 (机械呼吸,乳酸盐,心肺复苏) 是至关重要的.
- 保护因素 (IABP,BMI) 建议针对高风险的MI-CS患者进行量身定制干预的目标.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
3
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Acute Coronary SyndromeI: Introduction
18
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
18
Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1

